Remitly Global, Inc. (RELY)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	515.9	368.1	323.71	300.64	403.26	186.69
Cash & Short-Term Investments	515.9	368.1	323.71	300.64	403.26	186.69
Cash Growth	178.58%	13.71%	7.67%	-25.45%	116.00%	2.38%
Accounts Receivable	257.39	193.97	379.42	191.4	67.22	50.73
Other Receivables	36.55	19.06	18.41	6.53	-	-
Receivables	293.94	213.02	397.83	199.98	67.22	50.73
Prepaid Expenses	30.24	24.56	11.74	10.75	17.05	6.35
Restricted Cash	0.66	0.66	0.77	-	-	-
Other Current Assets	196.29	291.18	198.07	158.06	120.03	101.56
Total Current Assets	1,037	897.51	932.12	669.42	607.55	345.33
Property, Plant & Equipment	60.13	44.57	25.54	20.22	14.55	15.28
Goodwill	54.94	54.94	54.94	-	-	-
Other Intangible Assets	6.29	10.46	16.64	-	-	-
Long-Term Deferred Tax Assets	-	2.49	3.17	2.23	-	-
Long-Term Deferred Charges	3.1	0.8	1.2	1.19	0.5	-
Other Long-Term Assets	4.68	2.1	2.71	2.9	3.06	2.38
Total Assets	1,166	1,013	1,036	695.95	625.66	362.99
Accounts Payable	18.86	16.16	35.05	6.79	1.21	4.26
Accrued Expenses	81.49	73.23	61.24	55.44	44.63	19.79
Short-Term Debt	2.67	2.47	2.48	-	-	80
Current Portion of Leases	3.84	4.75	6.03	3.52	3.24	2.96
Current Income Taxes Payable	6.07	5.89	9.26	2.29	-	-
Other Current Liabilities	250.83	226.52	252.77	141.1	92.54	74.77
Total Current Liabilities	363.75	329.01	366.84	209.14	141.62	181.78
Long-Term Debt	-	-	130	-	-	-
Long-Term Leases	25.86	9.07	4.48	5.67	2.91	4.01
Other Long-Term Liabilities	11.64	9.32	5.65	1.05	0.81	0.83
Total Liabilities	401.25	347.4	506.97	215.87	145.34	186.61
Common Stock	0.02	0.02	0.02	0.02	0.02	0
Additional Paid-In Capital	1,271	1,195	1,020	854.28	739.5	8.77
Retained Earnings	-510.39	-528.28	-491.3	-373.46	-259.44	-220.69
Comprehensive Income & Other	4.18	-1.66	0.34	-0.74	0.25	0.59
Total Common Equity	764.92	665.47	529.34	480.09	480.33	-211.33
Shareholders' Equity	764.92	665.47	529.34	480.09	480.33	176.38
Total Liabilities & Equity	1,166	1,013	1,036	695.95	625.66	362.99
Total Debt	32.37	16.29	142.99	9.2	6.15	86.97
Net Cash (Debt)	483.53	351.81	180.72	291.44	397.12	99.73
Net Cash Growth	211.22%	94.67%	-37.99%	-26.61%	298.20%	-22.89%
Net Cash Per Share	2.32	1.81	1.00	1.74	6.54	4.65
Filing Date Shares Outstanding	206.19	200.61	188.51	174.19	166.08	24.29
Total Common Shares Outstanding	206.09	200.53	188.44	173.25	164.24	24.29
Working Capital	673.28	568.51	565.28	460.28	465.94	163.56
Book Value Per Share	3.71	3.32	2.81	2.77	2.92	-8.70
Tangible Book Value	703.69	600.07	457.76	480.09	480.33	-211.33
Tangible Book Value Per Share	3.41	2.99	2.43	2.77	2.92	-8.70
Machinery	15.82	11.29	11.17	8.23	6.15	4.81
Construction In Progress	1	7.67	-	0.72	0.53	-
Leasehold Improvements	20.68	8.72	8.08	7.04	6.66	6.61

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q